Neladenoson bialanate (BAY 1067197)

Phase 1Terminated
0 watching 0 views this week๐Ÿ’ค Quiet
30
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacology, Clinical

Conditions

Pharmacology, Clinical

Trial Timeline

Aug 24, 2017 โ†’ Dec 17, 2018

About Neladenoson bialanate (BAY 1067197)

Neladenoson bialanate (BAY 1067197) is a phase 1 stage product being developed by Bayer for Pharmacology, Clinical. The current trial status is terminated. This product is registered under clinical trial identifier NCT04322253. Target conditions include Pharmacology, Clinical.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT04320771Phase 1Terminated
NCT04322253Phase 1Terminated

Competing Products

16 competing products in Pharmacology, Clinical

See all competitors
ProductCompanyStageHype Score
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)BayerPhase 1
30
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspraยฎ) + PlaceboBayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)BayerPhase 1
30
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetilBayerPhase 1
30
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)BayerPhase 1
30
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + PlaceboBayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30
Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521)BayerPhase 1
30
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)BayerPhase 1
30
BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium + BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) + BAY 86-7660,levomefolate calciumBayerPhase 1
30
Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465)BayerPhase 1
30